Concord Medical Services Holdings Ltd (CCM)
0.67
+0.07
(+11.67%)
USD |
NYSE |
May 21, 16:00
0.67
0.00 (0.00%)
After-Hours: 20:00
Concord Medical Services Holdings Enterprise Value: 994.79M for May 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 20, 2024 | 994.79M |
May 17, 2024 | 990.59M |
May 16, 2024 | 991.36M |
May 15, 2024 | 993.91M |
May 14, 2024 | 991.32M |
May 13, 2024 | 992.23M |
May 10, 2024 | 992.23M |
May 09, 2024 | 993.05M |
May 08, 2024 | 995.45M |
May 07, 2024 | 996.19M |
May 06, 2024 | 993.92M |
May 03, 2024 | 996.09M |
May 02, 2024 | 999.13M |
May 01, 2024 | 1.002B |
April 30, 2024 | 1.006B |
April 29, 2024 | 998.26M |
April 26, 2024 | 994.37M |
April 25, 2024 | 990.62M |
April 24, 2024 | 993.49M |
April 23, 2024 | 993.92M |
April 22, 2024 | 990.46M |
April 19, 2024 | 992.62M |
April 18, 2024 | 994.06M |
April 17, 2024 | 996.23M |
April 16, 2024 | 996.23M |
Date | Value |
---|---|
April 15, 2024 | 996.09M |
April 12, 2024 | 996.09M |
April 11, 2024 | 996.09M |
April 10, 2024 | 996.52M |
April 09, 2024 | 996.53M |
April 08, 2024 | 995.88M |
April 05, 2024 | 993.84M |
April 04, 2024 | 995.53M |
April 03, 2024 | 994.79M |
April 02, 2024 | 992.92M |
April 01, 2024 | 991.32M |
March 28, 2024 | 992.75M |
March 27, 2024 | 994.23M |
March 26, 2024 | 995.09M |
March 25, 2024 | 986.59M |
March 22, 2024 | 988.34M |
March 21, 2024 | 987.41M |
March 20, 2024 | 986.11M |
March 19, 2024 | 986.15M |
March 18, 2024 | 988.27M |
March 15, 2024 | 989.58M |
March 14, 2024 | 986.11M |
March 13, 2024 | 987.93M |
March 12, 2024 | 986.55M |
March 11, 2024 | 986.98M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
417.51M
Minimum
Jun 18 2019
1.108B
Maximum
Mar 01 2022
879.38M
Average
986.76M
Median
Jul 07 2023
Enterprise Value Benchmarks
Dr Reddy's Laboratories Ltd | 10.63B |
ASLAN Pharmaceuticals Ltd | 19.41M |
111 Inc | 190.24M |
Zai Lab Ltd | 1.455B |
Sinovac Biotech Ltd | -7.011B |
Enterprise Value Related Metrics
Earnings Yield | -142.4% |
Normalized Earnings Yield | -165.89 |